HAE Financials
Haemonetics Corporation - Financial statements & key metrics
Stock Price
$101.95
Market Cap
$3.24B
P/E Ratio
24.2
EPS
$3.42
Income Statement Highlights
Most Recent Quarter: 2025-03-29
Revenue
$1.36B
Gross Profit
-
Operating Income
-
Net Income
$167.68M
EPS (Diluted)
$3.31
Balance Sheet Highlights
Total Assets
$2.45B
Total Liabilities
-
Shareholders Equity
-
Cash & Equivalents
$306.76M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$181.72M
CapEx
-
Free Cash Flow
-
Profitability Metrics
Operating Margin
21.0%
Net Margin
12.7%
ROE
19.5%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is HAE revenue?
HAE's most recent quarterly revenue was $1.36B. Annual revenue can be calculated by summing the four most recent quarters.
Is HAE profitable?
HAE reported a profit of $167.68M in the most recent quarter. The net profit margin is 12.7%.
What is HAE market cap?
HAE has a market capitalization of $3.24B, making it a mid-cap stock.
Does HAE have debt?
View HAE's balance sheet for debt information.
What is HAE cash flow?
Cash flow data is available in the full financial statements.